Skip to main content
logo
Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.27
-0.11 (-2.04%)
At close: Sep 24, 2026, 4:00 PM EDT
5.39
+0.12 (2.28%)
Pre-market: Sep 25, 2026, 4:12 AM EDT

Strata Critical Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
40.2241.35-27.31-56.08-27.26-36.92
Depreciation & Amortization
16.036.93.267.115.731.17
Loss (Gain) From Sale of Assets
0.34---0.07-
Asset Writedown & Restructuring Costs
4.782.715.7620.75--
Loss (Gain) From Sale of Investments
5.25.2--2.16-
Stock-Based Compensation
17.0117.8319.8912.58.2811.28
Provision & Write-off of Bad Debts
---0.16--
Other Operating Activities
-55.82-58.11-3.82-10.06-26.095.4
Change in Accounts Receivable
-5.77-12.03-1-10.25-5.35-1.74
Change in Accounts Payable
-1.182.38-8.349.059.92.52
Change in Unearned Revenue
-0.621.68-0.120.120.741.56
Change in Other Net Operating Assets
0.53-1.116.45-5.65-5.31-4.9
Operating Cash Flow
-36.03-48.91-2.52-32.35-37.13-21.63
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-12.42-9.6-30.86-2.11-0.73-0.49
Sale of Property, Plant & Equipment
---0.14--
Cash Acquisitions
-101.36-66.54-2.23--48.1-23.07
Divestitures
-3.1-2.81----
Sale (Purchase) of Intangibles
-1.07-1.42-2.12---12.36
Investment in Securities
119.45150.1134.219.06128.17-280.26
Investing Cash Flow
1.5169.75-1.0217.0979.34-316.17

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt Repaid
------1.17
Net Debt Issued (Repaid)
------1.17
Issuance of Common Stock
0.170.190.170.070.09335.04
Repurchase of Common Stock
-8.44-9.11-5.93-0.15-1.17-3.17
Financing Cash Flow
-8.6-8.91-5.76-0.08-1.08330.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.62-0.34-0.08-0.070.07-0.01
Net Cash Flow
-43.7411.59-9.37-15.441.2-7.11

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-48.45-58.51-33.38-34.46-37.86-22.12
Free Cash Flow Growth
------
Free Cash Flow Margin
-18.93%-29.68%-22.74%-15.30%-25.91%-32.93%
Free Cash Flow Per Share
-0.57-0.71-0.43-0.47-0.53-0.41
Levered Free Cash Flow
-20.09-26.98-28.89-11.67-18.34-
Unlevered Free Cash Flow
-20.09-26.98-28.89-11.67-18.34-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
0.160.09-0.02--
Change in Working Capital
-7.05-9.08-3.01-6.74-0.02-2.56
SEC Filings: 10-K · 10-Q